Canada Gairdner International Award

Canadian science pioneers' role in the Human Genome Project shows why it’s crucial to fund research

Retrieved on: 
Tuesday, April 25, 2023
Max Planck Institute for Evolutionary Anthropology, Nobel Prize, DNA, Book, Human, University, Human genome, DNA: The Story of Life, Collins, Genealogy book, Schizophrenia, Leadership, Survival, Cancer, Howard Hughes Medical Institute, MIT, Genome, Washington University in St. Louis, 2022 Nobel Prize in Physiology or Medicine, Pandemic, Climate change, Population, Patient, Map, Cystic fibrosis, McGill University, ARD International Music Competition, United Kingdom, Canada Gairdner International Award, Health, Human Genome Project, CF, Gene, Max Planck Society, Disease, Antibiotics, Vaccine, Pharmaceutical industry, Agriculture

For the Human Genome Project, Canadians were at the forefront.

Key Points: 
  • For the Human Genome Project, Canadians were at the forefront.
  • The meeting was attended by Nobel Prize winners Walter Gilbert and James Watson, and is described as a major catalyst for the Human Genome Project in The Book of Man: The Human Genome Project and the Quest to Discover Our Genetic Heritage.

From inspiration to sequencing the genome

    • Scriver was well aware of the significance sequencing the human genome would have on clinical genetics and the impact it would have on the health of patients, including identifying genetic causes of diseases.
    • To move forward from Scriver’s inspiration, a proof of principle project was needed.
    • One of these pioneers went on to lead the even more challenging Human Genome Project.
    • Read more:
      Closing the gender gap in the life sciences is an uphill struggle

      The consequences of the discovery of DNA and the sequencing of the Human Genome have been monumental for health research globally.

Can DNA Day be of significance in Canada?

    • The dedication of our accomplished discovery researchers Tsui, Riordan and Scriver inspired and led to the Human Genome Project.
    • In addition, John Sulston was funded in the United Kingdom as part of the trio who actually sequenced the human genome.
    • Scriver, Tsui and Riordan should inspire pride for the value of discovery research in Canada that globally saves human lives.
    • Canada should remember their legacy on DNA day.

IFF’s Philippe Horvath Inducted into The National Inventors Hall of Fame

Retrieved on: 
Monday, January 9, 2023
Biotechnology, Health, Specialty, Food, Beverage, Other Science, Cosmetics, Research, Infectious Diseases, Retail, Genetics, Science, All rights reserved, Degenerative disease, National Inventors Hall of Fame, Virus, Trademark, NYSE, Health, Franklin Institute Awards, Bacteria, Gene editing, International Flavors & Fragrances, Rodolphe Barrangou, Immune system, Creativity, Research, Massry Prize, North East of England Process Industry Cluster, Warren Alpert Foundation Prize, Canada Gairdner International Award, Horváth, Food, Vaccine, Perfume, CRISPR, D.C, Science

Philippe Horvath—renowned molecular biologist and IFF technical fellow—is being inducted into the National Inventors Hall of Fame® Class of 2023.

Key Points: 
  • Philippe Horvath—renowned molecular biologist and IFF technical fellow—is being inducted into the National Inventors Hall of Fame® Class of 2023.
  • Applying this research to enhance starter cultures in the dairy industry, Horvath and research partner Rodolphe Barrangou improved the world’s food supply and laid the foundation for the field of gene editing.
  • “We are proud of the achievements made by Philippe and the entire CRISPR team.
  • “I am deeply honored to be selected by the National Inventors Hall of Fame to represent the pioneering work our team has done,” said Horvath.

Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award

Retrieved on: 
Thursday, September 29, 2022
American Academy, Lasker Award, Safety, Canada Gairdner International Award, Center, City of Hope National Medical Center, Biology, Patient, Perseverance, Nasdaq, Sanford Burnham Prebys Medical Discovery Institute, Research, Disease, University of California, Santa Barbara, National Academy of Medicine, Life, DRS, CD34, Japan Prize, University of Helsinki, Tumor microenvironment, University of Turku, RGD, National Academy of Inventors, Integrin, California Institute for Quantitative Biosciences, Director, European, Neoplasm, Physiology, City, European Molecular Biology Organization, Board of directors, Tissue, GLOBE, Peptide, Health, Therapy, Thrombosis, National academy, CendR, Japan, Pancreatic cancer, Cell adhesion, Nanomedicine, Survival, Cancer, Cell, Medical research, RNA, Heart, University, Pharmaceutical industry, Technology, Science

The Albert Lasker Basic Medical Research Award is one of the highly competitive and distinguished international prizes for medical science awarded by the Lasker Foundation.

Key Points: 
  • The Albert Lasker Basic Medical Research Award is one of the highly competitive and distinguished international prizes for medical science awarded by the Lasker Foundation.
  • Lisata and its collaborators have also amassed significant non-clinical data demonstrating enhanced delivery of a range of emerging anti-cancer therapies, including immunotherapies and RNA-based therapeutics.
  • Lisata is exploring the potential of LSTA1 to enable a variety of treatment modalities to treat a range of solid tumors more effectively.
  • In addition, Lisata also has clinical development programs based on its autologous CD34+ cell therapy technology platform.

IconOVir Bio Appoints William Kaelin, Jr., M.D., to Board of Directors

Retrieved on: 
Thursday, June 23, 2022
Biotechnology, Health, Oncology, Eli Lilly and Company, American Academy, Internal medicine, Department, Department of Medicine – University of Pamplona, American Society for Clinical Investigation, Salk Institute for Biological Studies, Society, Canada Gairdner International Award, Dana–Farber Cancer Institute, Nobel Prize, Harvard Medical School, National Academy of Medicine, Howard Hughes Medical Institute, Damon Runyon Cancer Research Foundation, Technology, National, Company, Coronavirus Scientific Advisory Board (Turkey), AACR Awards, Biotechnology, Cancer, Oncology, Nobel Prize in Physiology or Medicine, Research, LinkedIn, Sidney, Duke University, Johns Hopkins, Patient, Board of directors, Board, Art, American Academy of Arts and Sciences, Therapy, National academy, Johns Hopkins Hospital, Pharmaceutical industry, Physiology, Director, Medicine, Science, Brigham

IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer, today announced the appointment of William G. Kaelin Jr., M.D., to its Board of Directors.

Key Points: 
  • IconOVir Bio, Inc. (IconOVir), a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer, today announced the appointment of William G. Kaelin Jr., M.D., to its Board of Directors.
  • Dr. Kaelin will continue to serve as a member of IconOVirs Scientific Advisory Board.
  • Over the past year, we have benefited greatly from Bills insights as a member of our Scientific Advisory Board.
  • IconOVir is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.

Dr. Roeland Nusse: Gairdner Award Recipient and Bio-Techne Board of Directors Member

Retrieved on: 
Wednesday, April 1, 2020
Biology, Canada Gairdner Wightman Award, Canada Gairdner Global Health Award, Awards, Canada Gairdner International Award, Roel Nusse, Culture, Officers of the Order of Canada, Gairdner Foundation

MINNEAPOLIS, April 1, 2020 /PRNewswire/ --Bio-Techne Corporation (NASDAQ:TECH) today announced a member of its board of directors, Dr. Roeland Nusse, has become one of the 2020 Canada Gairdner International Award recipients.

Key Points: 
  • MINNEAPOLIS, April 1, 2020 /PRNewswire/ --Bio-Techne Corporation (NASDAQ:TECH) today announced a member of its board of directors, Dr. Roeland Nusse, has become one of the 2020 Canada Gairdner International Award recipients.
  • Annually, seven awards are given: five Canada Gairdner International Awards for biomedical research, one John Dirks Canada Gairdner Global Health Award, specifically for impact on global health issues, and one Canada Gairdner Wightman Award, reserved for a Canadian.
  • Chuck Kummeth, President and CEO of Bio-Techne stated: "We are honored to have Dr. Nusse on our board of directors.
  • Dr. Nusse joins an impressive list of past recipients of the Gairdner Award, including Drs.